A comprehensive view of GoodRx Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
GoodRx announces preliminary fourth quarter and full year 2023 results and early expectations for first quarter and full year 2024
Published:
January 10, 2024
by GoodRx Inc.
|
GoodRx partnering with Sanofi to offer the insulin medication Lantus at flat rate of US$35 to both insured and uninsured diabetes patients in the US; the offer is available at over 70,000 US pharmacies accepting Good Rx, effectively immediately
Published:
October 19, 2023
by GoodRx Inc.
|
GoodRx partners with Walgreens, Walmart and Weis to offer savings on flu shots, antivirals and medications for the upcoming flu season; the company saved Americans over US$20.0M on flu treatments last season
Published:
September 21, 2023
by GoodRx Inc.
|
GoodRx and MedImpact unveil a new savings solution that automatically compares eligible member's benefit with GoodRx price for generic medication, with the lowest price being delivered; solution also enhances medication adherence and health outcomes
Published:
September 13, 2023
by GoodRx Inc.
|
GoodRx unveils Medicine Cabinet prescription management solution; Medicine Cabinet smartphone app helps consumers track prescriptions, get refill and daily pill reminders, find low prices, and earn rewards for staying on track
Published:
July 27, 2023
by GoodRx Inc.
|
Ask us about our Tissue & Hygiene market view